ESWT in the Treatment of Plantar Fasciitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorKirsehir Ahi Evran Universitesi

About this trial

Extracorporeal shock wave therapy (ESWT) has become widely preferred in Turkey and worldwide in recent years for the treatment of musculoskeletal diseases due to its non-invasive nature, ease of application, and low risk of complications, as it does not require surgical intervention. However, there is no consensus in the literature regarding the energy level used in ESWT applications, the frequency of application, and especially the ideal number of sessions. Different centers apply varying protocols in clinical practice, which can lead to heterogeneity in treatment outcomes. Scientifically determining the effect of variation in the number of ESWT sessions on clinical outcomes is important for establishing standard treatment protocols. Therefore, the aim of our study is to contribute to the existing literature by investigating the effect of variation in the number of ESWT sessions on clinical parameters such as pain, functional status, and quality of life in the treatment of chronic plantar fasciitis, and to develop more effective and evidence-based treatment approaches in patient management.

Eligibility criteria

Qualifiers

Patients aged 18-65, both male and female, diagnosed with plantar fasciitis based on anamnesis and physical examination.

Patients must have had symptoms for at least 3 months.

Patients must consent to participate in the study according to the informed consent form.

Disqualifiers

Complaint lasting less than 3 months

Having received an injection in the heel area within the last 6 months

Having applied physical therapy modalities to the heel area within the last 6 months

Bilateral complaint

Trial design

Treatments tested in this trial

  • Exercise group
  • 3 ESWT sessions
  • 5 ESWT sessions

Treatment groups

57 Participants
are divided into 3 treatment groups